Drugs / Sacubitril / Valsartan
last change May 2026 re-read 3 minutes ago

Sacubitril / Valsartan

Developed for
diastolic heart failure
Investigated by
University Clinical Hospital Mostar

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT07417215 Jan → May 2026 diastolic heart failure University Clinical Hospital Mostar Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Sacubitril / Valsartan ClinicalTrials.gov intervention name — accepted as the source's own label NCT07417215 ↗